Solara Active Pharma Sciences Limited — Others, 12-11-2024: Monitoring Agency Report

Solara Active Pharma Sciences Limited has provided the Monitoring Agency Report for the quarter ended September 30, 2024, concerning its Rights Issue, highlighting that all proceeds are utilized as per the disclosed objectives. The report confirms the repayment of ₹118.61 crore towards outstanding borrowings and ₹11.82 crore for general corporate purposes, out of the total net proceeds of ₹446.28 crore. No deviations were reported, and funding strategies remain intact. This transparency reinforces investor confidence, signaling a positive outlook for future operational stability as the company efficiently manages its capital structure.